These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26864167)

  • 1. Impact of gender on decisions to participate in faecal immunochemical test-based colorectal cancer screening: a qualitative study.
    Clarke N; Gallagher P; Kearney PM; McNamara D; Sharp L
    Psychooncology; 2016 Dec; 25(12):1456-1462. PubMed ID: 26864167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
    Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
    BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT).
    Denters MJ; Deutekom M; Essink-Bot ML; Bossuyt PM; Fockens P; Dekker E
    Health Expect; 2015 Oct; 18(5):839-49. PubMed ID: 23432931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative emotions and cancer fatalism are independently associated with uptake of Faecal Immunochemical Test-based colorectal cancer screening: Results from a population-based study.
    Clarke N; Kearney PM; Gallagher P; McNamara D; O'Morain CA; Sharp L
    Prev Med; 2021 Apr; 145():106430. PubMed ID: 33482227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT).
    Lim TZ; Lau J; Wong GJ; Tan LY; Chang YJ; Natarajan K; Yi H; Wong ML; Tan KK
    Cancer Med; 2021 Nov; 10(21):7735-7746. PubMed ID: 34519182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why colorectal screening fails to achieve the uptake rates of breast and cervical cancer screening: a comparative qualitative study.
    Kotzur M; McCowan C; Macdonald S; Wyke S; Gatting L; Campbell C; Weller D; Crighton E; Steele RJC; Robb KA
    BMJ Qual Saf; 2020 Jun; 29(6):482-490. PubMed ID: 31879320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.
    Duncan A; Turnbull D; Wilson C; Osborne JM; Cole SR; Flight I; Young GP
    BMC Public Health; 2014 Mar; 14():238. PubMed ID: 24606951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer.
    Hall NJ; Rubin GP; Dobson C; Weller D; Wardle J; Ritchie M; Rees CJ
    Health Expect; 2015 Oct; 18(5):1645-57. PubMed ID: 24268129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes.
    Molina-Barceló A; Salas Trejo D; Peiró-Pérez R; Málaga López A
    Eur J Cancer Care (Engl); 2011 Sep; 20(5):669-78. PubMed ID: 21771129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
    Dharni N; Armstrong D; Chung-Faye G; Wright AJ
    Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Patients' Experiences of Diagnosis and Treatment of Advanced Colorectal Cancer in a Safety-Net Hospital System: A Qualitative Study.
    Leal IM; Kao LS; Karanjawala B; Escamilla RJ; Ko TC; Millas SG
    Dis Colon Rectum; 2018 Apr; 61(4):504-513. PubMed ID: 29521833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived Deterrence Towards Colonoscopy for Colorectal Cancer Screening among Northern Malaysia Population: A Qualitative Study.
    Mohd Suan MA; Tan WL; Ismail I; Abu Hassan MR
    Asian Pac J Cancer Prev; 2020 May; 21(5):1253-1258. PubMed ID: 32458630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.
    Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z
    J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mundt MW; Spijker WJ; Bongers EJC; Kuipers EJ; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
    Gut; 2017 Nov; 66(11):1975-1982. PubMed ID: 27507905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emotional predictors of bowel screening: the avoidance-promoting role of fear, embarrassment, and disgust.
    Reynolds LM; Bissett IP; Consedine NS
    BMC Cancer; 2018 May; 18(1):518. PubMed ID: 29720112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for non-participation in the Northern Ireland Bowel Cancer Screening Programme: a qualitative study.
    Bradley DT; Treanor C; McMullan C; Owen T; Graham A; Anderson D
    BMJ Open; 2015 Sep; 5(9):e008266. PubMed ID: 26353870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust.
    Chambers JA; Callander AS; Grangeret R; O'Carroll RE
    BMC Cancer; 2016 Feb; 16():96. PubMed ID: 26872450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.